Suppr超能文献

关于去-精氨酸9-缓激肽体外及体内药理反应诱导的研究。

Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo.

作者信息

Bouthillier J, Deblois D, Marceau F

机构信息

Unité de Recherche Inflammation et Immuno-Rhumatologie, Centre Hospitalier de l'Université Laval, Québec, Canada.

出版信息

Br J Pharmacol. 1987 Oct;92(2):257-64. doi: 10.1111/j.1476-5381.1987.tb11319.x.

Abstract

1 The mechanisms by which agents modulate the induction of kinin B1-receptors were investigated by studying the effects of kinins in vitro, by use of the rabbit isolated aorta, and in vivo by measuring the blood pressure of anaesthetized rabbits. 2 The contractile response of the rabbit isolated aorta to kinins increased in a time-dependent manner in vitro. This effect was abolished by continuous exposure to the protein synthesis inhibitor cycloheximide (71 microM). 3 Several substances were found to increase specifically the rate of sensitization to des-Arg9-bradykinin (des-Arg9-Bk), when applied continuously in vitro to tissues isolated from normal animals: bacterial lipopolysaccharide (LPS; 1 micrograms ml-1), muramyl-dipeptide (MDP; 2 micrograms ml-1), phorbol myristate acetate (PMA; 320 nM), epidermal growth factor (EGF; 100 ng ml-1) and endothelial cell growth factor (150 micrograms ml-1). 4 The protease inhibitors phenylmethylsulphonyl fluoride and aprotinin, a non-adjuvant isomer of MDP, rabbit purified leukocyte interferon, fibroblast growth factor and the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) did not have this effect. 5. It has been demonstrated that LPS induces B1-receptors in rabbits enabling des-Arg9-Bk to act as a hypotensive agent. In these experiments neutropenia induced by nitrogen mustard, did not prevent the in vivo effect of LPS. MDP (300 micrograms) and PMA (100 micrograms) were also found to induce a state of responsiveness to des-Arg9-Bk in vivo. FMLP (1 mg i.v.) induced a temporary decrease in blood neutrophil counts but had no effect on the induction of responses to des-Arg9-Bk. 6. The development of responses mediated by the B,-receptor in the two experimental systems seems to be unrelated to the activation of neutrophil leukocytes, but may be related to the activation of tissue macrophages. Approximately 3% of cultured adherent cells derived from rabbit aorta strips following protease digestion were stained for non-specific esterase, supporting such a possibility.

摘要
  1. 通过在体外利用兔离体主动脉研究激肽的作用,并在体内通过测量麻醉兔的血压,来探究药物调节激肽B1受体诱导的机制。2. 在体外,兔离体主动脉对激肽的收缩反应呈时间依赖性增加。持续暴露于蛋白质合成抑制剂环己酰亚胺(71微摩尔)可消除此效应。3. 当在体外持续应用于从正常动物分离的组织时,发现几种物质能特异性增加对去-精氨酸9-缓激肽(des-Arg9-Bk)的致敏率:细菌脂多糖(LPS;1微克/毫升)、胞壁酰二肽(MDP;2微克/毫升)、佛波酯(PMA;320纳摩尔)、表皮生长因子(EGF;100纳克/毫升)和内皮细胞生长因子(150微克/毫升)。4. 蛋白酶抑制剂苯甲基磺酰氟和抑肽酶、MDP的一种非佐剂异构体、兔纯化白细胞干扰素、成纤维细胞生长因子以及趋化肽N-甲酰-L-蛋氨酰-L-亮氨酰-L-苯丙氨酸(FMLP)均无此作用。5. 已证明LPS可诱导兔体内的B1受体,使去-精氨酸9-缓激肽发挥降压作用。在这些实验中,氮芥诱导的中性粒细胞减少并未阻止LPS在体内的作用。还发现MDP(300微克)和PMA(100微克)在体内可诱导对去-精氨酸9-缓激肽的反应状态。FMLP(1毫克静脉注射)可使血液中性粒细胞计数暂时降低,但对去-精氨酸9-缓激肽反应的诱导无影响。6. 在这两个实验系统中,由B1受体介导的反应发展似乎与中性粒细胞的激活无关,但可能与组织巨噬细胞的激活有关。蛋白酶消化后从兔主动脉条衍生的约3%培养贴壁细胞经非特异性酯酶染色,支持了这种可能性。

相似文献

引用本文的文献

2
Kinin B receptor and TLR4 interaction in inflammatory response.缓激肽 B 受体与 TLR4 在炎症反应中的相互作用。
Inflamm Res. 2024 Sep;73(9):1459-1476. doi: 10.1007/s00011-024-01909-1. Epub 2024 Jul 4.
5
Kinins and Their Receptors in Infectious Diseases.激肽及其受体在传染病中的作用
Pharmaceuticals (Basel). 2020 Aug 27;13(9):215. doi: 10.3390/ph13090215.
6
COVID-19 cytokine storm: The anger of inflammation.COVID-19 细胞因子风暴:炎症的愤怒。
Cytokine. 2020 Sep;133:155151. doi: 10.1016/j.cyto.2020.155151. Epub 2020 May 30.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验